ATE318593T1 - Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut - Google Patents
Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter hautInfo
- Publication number
- ATE318593T1 ATE318593T1 AT98921064T AT98921064T ATE318593T1 AT E318593 T1 ATE318593 T1 AT E318593T1 AT 98921064 T AT98921064 T AT 98921064T AT 98921064 T AT98921064 T AT 98921064T AT E318593 T1 ATE318593 T1 AT E318593T1
- Authority
- AT
- Austria
- Prior art keywords
- tretinoin
- skin
- vehicle
- weight percent
- treated
- Prior art date
Links
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 abstract 6
- 229960001727 tretinoin Drugs 0.000 abstract 6
- 239000000203 mixture Substances 0.000 abstract 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- 208000017520 skin disease Diseases 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010003694 Atrophy Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010066295 Keratosis pilaris Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010051246 Photodermatosis Diseases 0.000 abstract 1
- 241001303601 Rosacea Species 0.000 abstract 1
- 206010040844 Skin exfoliation Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 230000037444 atrophy Effects 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 230000035618 desquamation Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000001804 emulsifying effect Effects 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 230000003810 hyperpigmentation Effects 0.000 abstract 1
- 208000000069 hyperpigmentation Diseases 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 201000004700 rosacea Diseases 0.000 abstract 1
- 230000037390 scarring Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 230000037303 wrinkles Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4607097P | 1997-05-09 | 1997-05-09 | |
| US09/071,017 US6008254A (en) | 1997-05-09 | 1998-05-01 | Method of treating skin disorders with high-strength tretinoin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE318593T1 true ATE318593T1 (de) | 2006-03-15 |
Family
ID=26723533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98921064T ATE318593T1 (de) | 1997-05-09 | 1998-05-11 | Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6008254A (de) |
| EP (1) | EP0980243B1 (de) |
| AT (1) | ATE318593T1 (de) |
| AU (1) | AU7374998A (de) |
| CA (1) | CA2288706C (de) |
| DE (1) | DE69833651T2 (de) |
| ES (1) | ES2260834T3 (de) |
| WO (1) | WO1998050023A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008254A (en) * | 1997-05-09 | 1999-12-28 | Kligman; Douglas E. | Method of treating skin disorders with high-strength tretinoin |
| AUPP583198A0 (en) * | 1998-09-11 | 1998-10-01 | Soltec Research Pty Ltd | Mousse composition |
| US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
| JP3942897B2 (ja) * | 2000-04-28 | 2007-07-11 | エフ．ホフマン−ラ ロシュ アーゲー | ｐ−（スルホニル）アリール及びヘテロアリール |
| US6353029B1 (en) * | 2000-08-24 | 2002-03-05 | Bristol-Myers Squibb Company | Storage stable tretinoin and 4-hydroxyanisole containing topical composition |
| CA2446356C (en) * | 2001-05-09 | 2012-07-10 | The Regents Of The University Of Michigan | Use of compositions for treating rosacea |
| US20050159485A1 (en) * | 2002-01-04 | 2005-07-21 | Jost-Price Edward R. | Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases |
| US20040097587A1 (en) * | 2002-03-27 | 2004-05-20 | Arbiser Jack L | Compositions and methods of treatment of ulcerating diseases, burns, and related conditions |
| US7704523B2 (en) * | 2002-04-26 | 2010-04-27 | Lohmann & Rauscher Gmbh | Microbial cellulose wound dressing for treating chronic wounds |
| US7390499B2 (en) | 2002-04-26 | 2008-06-24 | Lohmann & Rauscher Gmbh | Microbial cellulose wound dressing for treating chronic wounds |
| US20050019380A1 (en) * | 2002-04-26 | 2005-01-27 | Xylos Corporation | Microbial cellulose wound dressing for treating chronic wounds |
| US20030203013A1 (en) * | 2002-04-26 | 2003-10-30 | Xylos Corporation | Microbial cellulose wound dressing for treating chronic wounds |
| CA2556503A1 (en) * | 2004-02-19 | 2005-09-01 | Occell Inc. | Topical formulations for the treatment of skin conditions |
| FR2870125B1 (fr) * | 2004-05-12 | 2010-03-26 | Dermaconcept Jmc | Formulation du type spot-on utile en cosmetologie et en dermatologie |
| AU2005289313B2 (en) | 2004-09-28 | 2012-02-09 | Avivagen Inc. | Compositions and methods for promoting weight gain and feed conversion |
| MX2007006539A (es) * | 2004-12-02 | 2008-01-22 | Omp Inc | Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel. |
| AU2006226819A1 (en) * | 2005-03-24 | 2006-09-28 | Anacor Pharmaceuticals, Inc. | Topical formulations of boronic acid antibiotics and their methods of use |
| CA2611147C (en) | 2005-06-01 | 2013-04-09 | Stiefel Research Australia Pty Ltd. | Topical emulsion formulation |
| US20060294437A1 (en) * | 2005-06-22 | 2006-12-28 | Thunder Creative Technologies, Inc. | Point-of-load power conditioning for memory modules |
| US7709631B2 (en) | 2006-03-13 | 2010-05-04 | Xylos Corporation | Oxidized microbial cellulose and use thereof |
| US20070286884A1 (en) * | 2006-06-13 | 2007-12-13 | Xylos Corporation | Implantable microbial cellulose materials for hard tissue repair and regeneration |
| CA2686511A1 (fr) * | 2007-05-11 | 2008-11-20 | Galderma Research & Development | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
| DK2214656T3 (en) * | 2007-10-26 | 2019-03-25 | Avivagen Inc | COMPOSITIONS AND PROCEDURES TO ENHANCE IMMUNE RESPONSE |
| AU2010242502B2 (en) | 2009-04-30 | 2016-11-10 | Avivagen Inc. | Methods and compositions for improving the health of animals |
| EP3177365A4 (de) * | 2014-08-06 | 2018-01-10 | Thesan Pharmaceuticals, Inc. | Agonisten des ahr-rezeptorsignalweges mit sebosuppressiver aktivität und verfahren zur identifizierung dieser agonisten |
| BR112018008556A2 (pt) * | 2015-10-30 | 2018-10-23 | Patagonia Pharmaceuticals Llc | ?composições farmacêuticas e métodos para tratar ictiose congênita? |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3729568A (en) * | 1969-09-23 | 1973-04-24 | Johnson & Johnson | Acne treatment |
| US4603146A (en) * | 1984-05-16 | 1986-07-29 | Kligman Albert M | Methods for retarding the effects of aging of the skin |
| US4888342A (en) * | 1984-05-16 | 1989-12-19 | Kligman Albert M | Methods for treatment of sundamaged human skin with retinoids |
| US5019569A (en) * | 1986-11-03 | 1991-05-28 | Ortho Pharmaceutical Corporation | Reversal of glucocorticoid-induced skin atrophy |
| AU636595B2 (en) * | 1989-01-19 | 1993-05-06 | Ortho Pharmaceutical Corporation | Method for the treatment or prevention of intrinsically aged skin with retinoids |
| WO1992015290A1 (en) * | 1991-02-27 | 1992-09-17 | Kligman Albert M | Methods for treatment of scarring fibrotic alopecia |
| US5051449A (en) * | 1991-02-27 | 1991-09-24 | Kligman Albert M | Treatment of cellulite with retinoids |
| EP0625045A4 (de) * | 1992-02-07 | 1995-01-18 | Albert M Kligman | Verfahren zur behandlung von entzündlichen dermatosen. |
| AU670777B2 (en) * | 1992-04-16 | 1996-08-01 | Ortho Pharmaceutical Corporation | Aqueous gel vehicles for retinoids |
| US6008254A (en) * | 1997-05-09 | 1999-12-28 | Kligman; Douglas E. | Method of treating skin disorders with high-strength tretinoin |
-
1998
- 1998-05-01 US US09/071,017 patent/US6008254A/en not_active Expired - Lifetime
- 1998-05-11 ES ES98921064T patent/ES2260834T3/es not_active Expired - Lifetime
- 1998-05-11 CA CA002288706A patent/CA2288706C/en not_active Expired - Fee Related
- 1998-05-11 DE DE69833651T patent/DE69833651T2/de not_active Expired - Fee Related
- 1998-05-11 WO PCT/US1998/009440 patent/WO1998050023A1/en not_active Ceased
- 1998-05-11 AU AU73749/98A patent/AU7374998A/en not_active Abandoned
- 1998-05-11 EP EP98921064A patent/EP0980243B1/de not_active Expired - Lifetime
- 1998-05-11 AT AT98921064T patent/ATE318593T1/de not_active IP Right Cessation
-
2000
- 2000-05-09 US US09/567,792 patent/US6228887B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2260834T3 (es) | 2006-11-01 |
| DE69833651D1 (de) | 2006-04-27 |
| EP0980243A1 (de) | 2000-02-23 |
| CA2288706A1 (en) | 1998-11-12 |
| AU7374998A (en) | 1998-11-27 |
| DE69833651T2 (de) | 2006-12-28 |
| EP0980243B1 (de) | 2006-03-01 |
| WO1998050023A1 (en) | 1998-11-12 |
| CA2288706C (en) | 2007-10-16 |
| US6228887B1 (en) | 2001-05-08 |
| US6008254A (en) | 1999-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE318593T1 (de) | Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut | |
| WANG et al. | The effect of glycolic acid on the treatment of acne in Asian skin | |
| Piérard-Franchimont et al. | A randomized, placebo-controlled trial of topical retinol in the treatment of cellulite | |
| Glogau et al. | Chemical peels: trichloroacetic acid and phenol | |
| Ehrlich et al. | Improvement in the appearance of wrinkles with topical transforming growth factor β1 and L-ascorbic acid | |
| RU94045258A (ru) | Косметическая или дерматологическая композиция для одновременного лечения поверхностных и глубоких слоев кожи и ее применение | |
| RU94045136A (ru) | Композиция для ухода за кожей, способ ухода за кожей | |
| BR0015604A (pt) | Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas | |
| DE59410301D1 (de) | Topische zubereitungen mit einem gehalt an l-arginin | |
| PT2052714E (pt) | Sistemas de distribuição tópica em gel para tratamento de distúrbios da pele | |
| ES2020011A6 (es) | Metodo de sintesis de composiciones que comprenden al menos un butano fenolico. | |
| BR9711671A (pt) | Tratamento com ácido graxo. | |
| ATE398995T1 (de) | Hautpflegemittel die salicylsäure enthalten | |
| NO944958D0 (no) | Kosmetisk preparat, fremgangsmåte for fremstilling av dette, samt anvendelse derav | |
| CA2157836A1 (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses | |
| Rubin | Trichloroacetic acid and other non-phenol peels | |
| EP0801945A3 (de) | Verwendung von Glucosiden von Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen | |
| GB2210789A (en) | Topical application for skin care | |
| CA2065412C (en) | Methods of preventing and reducing the size of striae distensae lesions | |
| DE69503724D1 (de) | L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen | |
| DE69717495D1 (de) | Verwendung eines terminalia catappa extraktes | |
| CN115518006A (zh) | 一种维护稳定皮肤屏障的水脂膜在护肤品中的应用及制备方法 | |
| BR0010121A (pt) | Uso de compostos policìclicos aromáticos comoativadores dos receptores de tipo ppars eprocesso de tratamento cosmético | |
| JPH07508040A (ja) | セレノアミノ酸の経皮適用による外因性皮膚老化の再生 | |
| RU2683248C1 (ru) | Композиция лосьона для ухода после бритья за кожей лица, имеющей угревые высыпания |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |